Showing results (21-30 of 72) with videos related to
Sort By:
Pageof 8
Revue Medicale De Liege|April 11, 2024
[Patient with type 2 diabetes and coronary heart disease developing heart failure]André Scheen, Nicolas Paquot, Patrizio LancellottiRevue Medicale De Liege|June 23, 2023
[Reactive hypoglycaemia, a frequently mentioned functional disorder, yet overestimated in clinical practice]André Scheen, Nicolas Paquot, Pierre LefèbvreExpert Opinion on Investigational Drugs|October 28, 2014
Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular diseaseNathalie Esser, Nicolas Paquot, André J ScheenRevue Medicale Suisse|September 22, 2010
[Reduction of obesity-related metabolic risk by modulating tissue exposition to cortisol]Alessandra Iovino, Nicolas Paquot, André J ScheenRevue Medicale De Liege|March 16, 2023
[Anti-obesity drugs : from previous disappointments to new hopes]André Scheen, Jenny De Flines, Nicolas PaquotRevue Medicale Suisse|August 23, 2019
[Long-term management after bariatric surgery]Jenny De Flines, Andre Scheen, Nicolas PaquotRevue Medicale Suisse|August 28, 2020
[Strategies of home parenteral nutrition in adult patients in 2020]Huu Hanh Lê, Jenny De Flines, Nicolas PaquotRevue Medicale De Liege|June 16, 2025
[Guidelines for the basic management of chronic kidney disease]Pierre Delanaye, Nicolas Paquot, François Jouret, et al.Revue Medicale Suisse|August 23, 2019
[Potential role of SGLT2 inhibitors in the management of type 1 diabetes]Jean-Christophe Philips, Nicolas Paquot, Andre J ScheenExpert Opinion on Investigational Drugs|October 21, 2017
Investigational glucagon receptor antagonists in Phase I and II clinical trials for diabetesAndré J Scheen, Nicolas Paquot, Pierre J LefèbvrePageof 8